ÐÓ°ÉÔ­´´

Caeli Nova shows strong potential with its innovative technology serving both the medical and aviation sectors. Based in London and operating on a B2B model, it addresses inefficiencies and risks in current protocols. By offering solutions that enhance existing systems, Caeli Nova uniquely bridges two highly regulated industries. This value proposition sets it apart and positions it for significant impact and growth. Backed by investors like LG Capital, the company is well-placed to develop and market its technology, driving advancements in both fields.